A detailed history of Roubaix Capital, LLC transactions in Staar Surgical CO stock. As of the latest transaction made, Roubaix Capital, LLC holds 81,114 shares of STAA stock, worth $1.96 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares
81,114
Previous 90,172 10.05%
Holding current value
$1.96 Million
Previous $4.29 Million 29.82%
% of portfolio
1.99%
Previous 3.1%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$29.97 - $47.42 $271,468 - $429,530
-9,058 Reduced 10.05%
81,114 $3.01 Million
Q2 2024

Aug 02, 2024

BUY
$38.07 - $52.25 $3.43 Million - $4.71 Million
90,172 New
90,172 $4.29 Million
Q4 2022

Feb 06, 2023

BUY
$46.82 - $76.2 $2.66 Million - $4.32 Million
56,756 New
56,756 $2.75 Million
Q2 2022

Aug 05, 2022

BUY
$50.24 - $80.48 $318,421 - $510,082
6,338 Added 8.91%
77,472 $5.5 Million
Q1 2022

Apr 19, 2022

BUY
$57.98 - $93.5 $4.12 Million - $6.65 Million
71,134 New
71,134 $5.68 Million
Q4 2020

Feb 11, 2021

SELL
$55.93 - $82.78 $1.59 Million - $2.36 Million
-28,512 Closed
0 $0
Q3 2020

Nov 03, 2020

SELL
$45.65 - $61.81 $304,302 - $412,025
-6,666 Reduced 18.95%
28,512 $1.61 Million
Q2 2020

Jul 28, 2020

SELL
$29.15 - $61.54 $101,063 - $213,359
-3,467 Reduced 8.97%
35,178 $2.17 Million
Q1 2020

Apr 15, 2020

BUY
$25.01 - $42.4 $966,511 - $1.64 Million
38,645 New
38,645 $1.25 Million
Q3 2019

Oct 08, 2019

SELL
$25.78 - $34.8 $2.24 Million - $3.03 Million
-87,004 Closed
0 $0
Q2 2019

Jul 30, 2019

BUY
$23.08 - $37.01 $2.01 Million - $3.22 Million
87,004 New
87,004 $2.56 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.16B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Roubaix Capital, LLC Portfolio

Follow Roubaix Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roubaix Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roubaix Capital, LLC with notifications on news.